MORGAN WEINSTEIN: Open Payments
NPI 1851927552 · BRADENTON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,582 in 128 payments from 27 companies in 2025. Trend: 2023 $3,580 · 2024 $2,437 · 2025 $2,582
Food & beverage: $2,582
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 20 | $247 |
| UCB, Inc. | 9 | $213 |
| ABBVIE INC. | 10 | $209 |
| Lilly USA, LLC | 11 | $200 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $168 |
| EMD Serono, Inc. | 7 | $160 |
| Teva Pharmaceuticals USA, Inc. | 13 | $160 |
| GE HEALTHCARE | 6 | $139 |
| Neurocrine BioSciences, Inc. | 5 | $138 |
| Eisai Inc. | 5 | $115 |
Products named: KISUNLA, HYQVIA, NURTEC ODT, AUSTEDO XR, INGREZZA, Zilbrysq, Leqembi, UBRELVY.
Industry payments across FL — which companies pay providers there.
